HEPATO CELLULAR CARCINOMA (HCC)
Clinical trials for HEPATO CELLULAR CARCINOMA (HCC) explained in plain language.
Never miss a new study
Get alerted when new HEPATO CELLULAR CARCINOMA (HCC) trials appear
Sign up with your email to follow new studies for HEPATO CELLULAR CARCINOMA (HCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Can Pre-Surgery immunotherapy stop liver cancer from coming back?
Disease control Not yet recruitingThis study tests whether giving an immunotherapy drug (atezolizumab) before surgery can help the immune system fight liver cancer more effectively. About 30 adults with early-stage liver cancer will receive the drug before their tumor is removed. The goal is to see if this approa…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE3 • Sponsor: University of Geneva, Switzerland • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New combo therapy aims to slash liver cancer recurrence after surgery
Disease control Not yet recruitingThis study tests whether combining local treatments (TACE or ablation) with immunotherapy drugs (sintilimab and ipilimumab) before surgery can lower the chance of liver cancer coming back. It involves 105 adults with resectable liver cancer at intermediate-to-high risk of recurre…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Sun Yat-sen University • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
New drug combo targets tough liver and kidney cancers
Disease control Not yet recruitingThis study tests a new drug called WGI-0301 combined with nivolumab in people with advanced liver or kidney cancer. The goal is to see if the combination is safe and shows signs of shrinking tumors. About 230 adults aged 18 to 75 will take part at multiple hospitals, with no plac…
Matched conditions: HEPATO CELLULAR CARCINOMA (HCC)
Phase: PHASE2 • Sponsor: Zhejiang Haichang Biotech Co., Ltd. • Aim: Disease control
Last updated May 07, 2026 18:41 UTC